Financial Management Professionals Inc. raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4,185.7% during the second quarter, HoldingsChannel reports. The fund owned 12,000 shares of the exchange traded fund’s stock after purchasing an additional 11,720 shares during the quarter. Financial Management Professionals Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,899,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Axiom Investment Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the first quarter valued at $26,000. Financial Life Planners bought a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter valued at $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $30,000. Finally, SHP Wealth Management bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth about $31,000.
SPDR S&P Biotech ETF Stock Up 0.4%
Shares of NYSEARCA XBI opened at $158.03 on Tuesday. The company has a market cap of $10.32 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 52 week low of $84.81 and a 52 week high of $165.71. The business has a 50-day simple moving average of $148.49 and a two-hundred day simple moving average of $135.64.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
